These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

158 related items for PubMed ID: 11371695

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Symptomatic hyperlactatemia associated with nucleoside analogue reverse-transcriptase inhibitor use in HIV-infected patients: a report of 24 cases in a resource-limited setting (Uganda).
    Songa PM, Castelnuovo B, Mugasha EB, Ocama P, Kambugu A.
    Clin Infect Dis; 2007 Aug 15; 45(4):514-7. PubMed ID: 17638205
    [Abstract] [Full Text] [Related]

  • 3. [Lactic acidosis following antiretroviral therapy].
    Moreno-Cuerda VJ, Rubio García R.
    Med Clin (Barc); 2005 Jul 09; 125(6):213-4. PubMed ID: 16022834
    [No Abstract] [Full Text] [Related]

  • 4. [Treatment of symptomatic hyperlactatemia and lactic acidosis in HIV+ patients under nucleoside reverse transcriptase inhibitors].
    Pedrol E, Ribell M, Deig E, Villà Mdel C, Miró O, Garrabou G, Soler A.
    Med Clin (Barc); 2005 Jul 09; 125(6):201-4. PubMed ID: 16022831
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Human immunodeficiency virus infection with human granulocytic ehrlichiosis complicated by symptomatic lactic acidosis.
    Springer SA, Altice FL.
    Clin Infect Dis; 2003 Jun 15; 36(12):e162-4. PubMed ID: 12802782
    [Abstract] [Full Text] [Related]

  • 7. [Lactic acidosis in HIV-patients--diagnosis and treatment].
    Walker UA.
    MMW Fortschr Med; 2004 Apr 26; 146 Spec No 1():65-7. PubMed ID: 15373054
    [Abstract] [Full Text] [Related]

  • 8. Bench-to-bedside review: severe lactic acidosis in HIV patients treated with nucleoside analogue reverse transcriptase inhibitors.
    Claessens YE, Chiche JD, Mira JP, Cariou A.
    Crit Care; 2003 Jun 26; 7(3):226-32. PubMed ID: 12793872
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Frequency, risk factors, and outcome of hyperlactatemia in HIV-positive persons: implications for the management of treated patients.
    Marceau G, Sapin V, Jacomet C, Ughetto S, Cormerais L, Regagnon C, Dastugue B, Peigue-Lafeuille H, Beytout J, Laurichesse H.
    Clin Chem; 2003 Jul 26; 49(7):1154-62. PubMed ID: 12816913
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Update on mitochondrial toxicity of antiretrovirals and its link to lipodystrophy.
    McComsey G.
    AIDS Rev; 2002 Jul 26; 4(3):140-7. PubMed ID: 12416448
    [Abstract] [Full Text] [Related]

  • 19. Anti-HIV drugs and the mitochondria.
    Pinti M, Salomoni P, Cossarizza A.
    Biochim Biophys Acta; 2006 Jul 26; 1757(5-6):700-7. PubMed ID: 16782042
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.